APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Trial Imaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Clinical Trial Imaging Market Outlook and Growth Opportunities 2026

4 June 2026191 pages

Choose your research edition.

Industry ResearchAI Clinical Trial Imaging Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Trial Imaging Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal AI Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Trial Imaging Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Trial Imaging Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global AI Clinical Trial Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Clinical Trial Imaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Clinical Trial Imaging market include AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI and Quibim, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Clinical Trial Imaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Clinical Trial Imaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Clinical Trial Imaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Clinical Trial Imaging market.

AI Clinical Trial Imaging Segment by Company

AICure

Brainomix

Clario

Lantern Pharma

Median

Neuroute

Owkin

PathAI

Quibim

Saama

Spectral

VIDA

Voiant

AI Clinical Trial Imaging Segment by Type

Based on Machine Learning

Based on Deep Learning

Others

AI Clinical Trial Imaging Segment by Application

Telemedicine

Diagnostic Assistance

Clinical Decision Support

Others

AI Clinical Trial Imaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Clinical Trial Imaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Clinical Trial Imaging key companies, revenue, market share, and recent developments.

3. To split the AI Clinical Trial Imaging breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Clinical Trial Imaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Clinical Trial Imaging significant trends, drivers, influence factors in global and regions.

6. To analyze AI Clinical Trial Imaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Imaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Trial Imaging industry.

Chapter 3: Detailed analysis of AI Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Clinical Trial Imaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Clinical Trial Imaging Industry Trends Table 2. AI Clinical Trial Imaging Industry Drivers Table 3. AI Clinical Trial Imaging Industry Opportunities and Challenges Table 4. AI Clinical Trial Imaging Industry Restraints Table 5. Global AI Clinical Trial Imaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Clinical Trial Imaging Revenue Share by Company (2021-2026) Table 7. Global AI Clinical Trial Imaging Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Clinical Trial Imaging Key Company Manufacturing Base & Headquarters Table 9. Global AI Clinical Trial Imaging Company, Product Type & Application Table 10. Global AI Clinical Trial Imaging Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Clinical Trial Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Based on Machine Learning Table 15. Significant Companies of Based on Deep Learning Table 16. Significant Companies of Others Table 17. Global AI Clinical Trial Imaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global AI Clinical Trial Imaging Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global AI Clinical Trial Imaging Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global AI Clinical Trial Imaging Sales Value Share by Type (2021-2026) Table 21. Global AI Clinical Trial Imaging Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Telemedicine Table 23. Significant Companies of Diagnostic Assistance Table 24. Significant Companies of Clinical Decision Support Table 25. Significant Companies of Others Table 26. Global AI Clinical Trial Imaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Clinical Trial Imaging Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Clinical Trial Imaging Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Clinical Trial Imaging Sales Value Share by Application (2021-2026) Table 30. Global AI Clinical Trial Imaging Sales Value Share by Application (2027-2032) Table 31. Global AI Clinical Trial Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Clinical Trial Imaging Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Clinical Trial Imaging Sales Value Share by Region (2021-2026) Table 34. Global AI Clinical Trial Imaging Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Clinical Trial Imaging Sales Value Share by Region (2027-2032) Table 36. Global AI Clinical Trial Imaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Clinical Trial Imaging Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Clinical Trial Imaging Sales Value Market Share by Country (2021-2026) Table 39. Global AI Clinical Trial Imaging Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Clinical Trial Imaging Sales Value Market Share by Country (2027-2032) Table 41. AICure Company Information Table 42. AICure Business Overview Table 43. AICure AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. AICure AI Clinical Trial Imaging Product Portfolio Table 45. AICure Recent Development Table 46. Brainomix Company Information Table 47. Brainomix Business Overview Table 48. Brainomix AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Brainomix AI Clinical Trial Imaging Product Portfolio Table 50. Brainomix Recent Development Table 51. Clario Company Information Table 52. Clario Business Overview Table 53. Clario AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Clario AI Clinical Trial Imaging Product Portfolio Table 55. Clario Recent Development Table 56. Lantern Pharma Company Information Table 57. Lantern Pharma Business Overview Table 58. Lantern Pharma AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Lantern Pharma AI Clinical Trial Imaging Product Portfolio Table 60. Lantern Pharma Recent Development Table 61. Median Company Information Table 62. Median Business Overview Table 63. Median AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Median AI Clinical Trial Imaging Product Portfolio Table 65. Median Recent Development Table 66. Neuroute Company Information Table 67. Neuroute Business Overview Table 68. Neuroute AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Neuroute AI Clinical Trial Imaging Product Portfolio Table 70. Neuroute Recent Development Table 71. Owkin Company Information Table 72. Owkin Business Overview Table 73. Owkin AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Owkin AI Clinical Trial Imaging Product Portfolio Table 75. Owkin Recent Development Table 76. PathAI Company Information Table 77. PathAI Business Overview Table 78. PathAI AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. PathAI AI Clinical Trial Imaging Product Portfolio Table 80. PathAI Recent Development Table 81. Quibim Company Information Table 82. Quibim Business Overview Table 83. Quibim AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Quibim AI Clinical Trial Imaging Product Portfolio Table 85. Quibim Recent Development Table 86. Saama Company Information Table 87. Saama Business Overview Table 88. Saama AI Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Saama AI Clinical Trial Imaging Product Portfolio Table 90. Saama Recent Development Table 91. Spectral Company Information Table 92. Spectral Business Overview Table 93. Spectral AI Clinical Trial Imaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Spectral AI Clinical Trial Imaging Product Portfolio Table 95. Spectral Recent Development Table 96. VIDA Company Information Table 97. VIDA Business Overview Table 98. VIDA AI Clinical Trial Imaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. VIDA AI Clinical Trial Imaging Product Portfolio Table 100. VIDA Recent Development Table 101. Voiant Company Information Table 102. Voiant Business Overview Table 103. Voiant AI Clinical Trial Imaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Voiant AI Clinical Trial Imaging Product Portfolio Table 105. Voiant Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. AI Clinical Trial Imaging Product Image Figure 2. Global AI Clinical Trial Imaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Clinical Trial Imaging Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Clinical Trial Imaging Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Based on Machine Learning Image Figure 8. Based on Deep Learning Image Figure 9. Others Image Figure 10. Global AI Clinical Trial Imaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global AI Clinical Trial Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global AI Clinical Trial Imaging Sales Value Share by Type (2021-2032) Figure 13. Telemedicine Image Figure 14. Diagnostic Assistance Image Figure 15. Clinical Decision Support Image Figure 16. Others Image Figure 17. Global AI Clinical Trial Imaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Clinical Trial Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Clinical Trial Imaging Sales Value Share by Application (2021-2032) Figure 20. Global AI Clinical Trial Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Clinical Trial Imaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Based on Machine Learning
  • Based on Deep Learning
  • Others
Applications
  • Telemedicine
  • Diagnostic Assistance
  • Clinical Decision Support
  • Others
Companies covered
  • AICure
  • Brainomix
  • Clario
  • Lantern Pharma
  • Median
  • Neuroute
  • Owkin
  • PathAI
  • Quibim
  • Saama
  • Spectral
  • VIDA
  • Voiant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Clinical Trial Imaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Clinical Trial Imaging Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Clinical Trial Imaging Market Dynamics
  1. 2.1 AI Clinical Trial Imaging Industry Trends
  2. 2.2 AI Clinical Trial Imaging Industry Drivers
  3. 2.3 AI Clinical Trial Imaging Industry Opportunities and Challenges
  4. 2.4 AI Clinical Trial Imaging Industry Restraints
3 AI Clinical Trial Imaging Market by Company
  1. 3.1 Global AI Clinical Trial Imaging Company Revenue Ranking in 2025
  2. 3.2 Global AI Clinical Trial Imaging Revenue by Company (2021-2026)
  3. 3.3 Global AI Clinical Trial Imaging Company Ranking (2024-2026)
  4. 3.4 Global AI Clinical Trial Imaging Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Clinical Trial Imaging Company Product Type and Application
  6. 3.6 Global AI Clinical Trial Imaging Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Clinical Trial Imaging Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Clinical Trial Imaging Market by Type
  1. 4.1 AI Clinical Trial Imaging Type Introduction
  2. 4.1.1 Based on Machine Learning
  3. 4.1.2 Based on Deep Learning
  4. 4.1.3 Others
  5. 4.2 Global AI Clinical Trial Imaging Sales Value by Type
  6. 4.2.1 Global AI Clinical Trial Imaging Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global AI Clinical Trial Imaging Sales Value by Type (2021-2032)
  8. 4.2.3 Global AI Clinical Trial Imaging Sales Value Share by Type (2021-2032)
5 AI Clinical Trial Imaging Market by Application
  1. 5.1 AI Clinical Trial Imaging Application Introduction
  2. 5.1.1 Telemedicine
  3. 5.1.2 Diagnostic Assistance
  4. 5.1.3 Clinical Decision Support
  5. 5.1.4 Others
  6. 5.2 Global AI Clinical Trial Imaging Sales Value by Application
  7. 5.2.1 Global AI Clinical Trial Imaging Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Clinical Trial Imaging Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Clinical Trial Imaging Sales Value Share by Application (2021-2032)
6 AI Clinical Trial Imaging Regional Value Analysis
  1. 6.1 Global AI Clinical Trial Imaging Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Clinical Trial Imaging Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Clinical Trial Imaging Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Clinical Trial Imaging Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Clinical Trial Imaging Sales Value (2021-2032)
  7. 6.3.2 North America AI Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Clinical Trial Imaging Sales Value (2021-2032)
  10. 6.4.2 Europe AI Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Clinical Trial Imaging Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Clinical Trial Imaging Sales Value (2021-2032)
  16. 6.6.2 South America AI Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Clinical Trial Imaging Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
7 AI Clinical Trial Imaging Country-level Value Analysis
  1. 7.1 Global AI Clinical Trial Imaging Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Clinical Trial Imaging Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Clinical Trial Imaging Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Clinical Trial Imaging Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AICure
  2. 8.1.1 AICure Company Information
  3. 8.1.2 AICure Business Overview
  4. 8.1.3 AICure AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AICure AI Clinical Trial Imaging Product Portfolio
  6. 8.1.5 AICure Recent Developments
  7. 8.2 Brainomix
  8. 8.2.1 Brainomix Company Information
  9. 8.2.2 Brainomix Business Overview
  10. 8.2.3 Brainomix AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Brainomix AI Clinical Trial Imaging Product Portfolio
  12. 8.2.5 Brainomix Recent Developments
  13. 8.3 Clario
  14. 8.3.1 Clario Company Information
  15. 8.3.2 Clario Business Overview
  16. 8.3.3 Clario AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Clario AI Clinical Trial Imaging Product Portfolio
  18. 8.3.5 Clario Recent Developments
  19. 8.4 Lantern Pharma
  20. 8.4.1 Lantern Pharma Company Information
  21. 8.4.2 Lantern Pharma Business Overview
  22. 8.4.3 Lantern Pharma AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lantern Pharma AI Clinical Trial Imaging Product Portfolio
  24. 8.4.5 Lantern Pharma Recent Developments
  25. 8.5 Median
  26. 8.5.1 Median Company Information
  27. 8.5.2 Median Business Overview
  28. 8.5.3 Median AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Median AI Clinical Trial Imaging Product Portfolio
  30. 8.5.5 Median Recent Developments
  31. 8.6 Neuroute
  32. 8.6.1 Neuroute Company Information
  33. 8.6.2 Neuroute Business Overview
  34. 8.6.3 Neuroute AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neuroute AI Clinical Trial Imaging Product Portfolio
  36. 8.6.5 Neuroute Recent Developments
  37. 8.7 Owkin
  38. 8.7.1 Owkin Company Information
  39. 8.7.2 Owkin Business Overview
  40. 8.7.3 Owkin AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Owkin AI Clinical Trial Imaging Product Portfolio
  42. 8.7.5 Owkin Recent Developments
  43. 8.8 PathAI
  44. 8.8.1 PathAI Company Information
  45. 8.8.2 PathAI Business Overview
  46. 8.8.3 PathAI AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PathAI AI Clinical Trial Imaging Product Portfolio
  48. 8.8.5 PathAI Recent Developments
  49. 8.9 Quibim
  50. 8.9.1 Quibim Company Information
  51. 8.9.2 Quibim Business Overview
  52. 8.9.3 Quibim AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Quibim AI Clinical Trial Imaging Product Portfolio
  54. 8.9.5 Quibim Recent Developments
  55. 8.10 Saama
  56. 8.10.1 Saama Company Information
  57. 8.10.2 Saama Business Overview
  58. 8.10.3 Saama AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Saama AI Clinical Trial Imaging Product Portfolio
  60. 8.10.5 Saama Recent Developments
  61. 8.11 Spectral
  62. 8.11.1 Spectral Company Information
  63. 8.11.2 Spectral Business Overview
  64. 8.11.3 Spectral AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Spectral AI Clinical Trial Imaging Product Portfolio
  66. 8.11.5 Spectral Recent Developments
  67. 8.12 VIDA
  68. 8.12.1 VIDA Company Information
  69. 8.12.2 VIDA Business Overview
  70. 8.12.3 VIDA AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VIDA AI Clinical Trial Imaging Product Portfolio
  72. 8.12.5 VIDA Recent Developments
  73. 8.13 Voiant
  74. 8.13.1 Voiant Company Information
  75. 8.13.2 Voiant Business Overview
  76. 8.13.3 Voiant AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Voiant AI Clinical Trial Imaging Product Portfolio
  78. 8.13.5 Voiant Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst